Renal Sympathetic Denervation in Atrial Fibrillation Treatment

Abstract

Atrial fibrillation (AF) is a chronic and progressive disease. The most common causes of AF are age and hypertension. Treatment is challenging and the main treatment is medical. Despite optimal medical treatment in accordance with guidelines, many patients remain symptomatic. At this stage, catheter ablation-based applications have made a breakthrough in the treatment of AF. Pulmonary vein isolation is the cornerstone of treatment, but pulmonary vein isolation is often not sufficient. Identification of additional isolation sites and targeting these sites has been essential in the treatment of atrial fibrillation. Therefore, new treatment strategies are being sought. While renal sympathetic denervation was initially used in the treatment of resistant hypertension, its efficacy in the treatment of cardiac arrhythmias, including AF, has been established. In this article, we will describe the role of renal sympathetic denervation in the treatment of AF and will not include a comparison with other treatments.